Glintborg, B <br/><br/>
Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care.  [electronic resource] 

 -  Scandinavian journal of rheumatology  09 2018 
 - 418-421 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>1502-7732 
<br/><br/><label>Standard No.: </label>10.1080/03009742.2017.1376110  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies--blood<br/>Antibodies, Monoclonal--blood<br/>Arthritis--blood<br/>Denmark<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Infliximab--administration & dosage<br/>Male<br/>Middle Aged